Disclosure Of Entity's Operating Segments [Text Block]

Medistim - Filing #5830287

Concept	As at 2024-12-31	2024-01-01 to 2024-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31
Disclosure of entity's operating segments [text block]	—		—	—
Disclosure of operating segments [text block]	—	—	—	—
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Revenue	—	556 164 NOK	—	521 109 NOK
Depreciation and amortisation expense	—	24 510 NOK	—	23 657 NOK
Tax expense (income)	—	30 414 NOK	—	31 389 NOK
Profit (loss) before tax	—	134 246 NOK	—	135 212 NOK
Profit (loss)	—	103 832 NOK	—	103 823 NOK
Assets	574 968 NOK	—	505 718 NOK	—
Liabilities	138 357 NOK	—	107 777 NOK	—
Cash flows from (used in) operating activities	—	143 104 NOK	—	119 198 NOK
Cash flows from (used in) investing activities	—	24 693 NOK	—	29 726 NOK
Cash flows from (used in) financing activities	—	91 529 NOK	—	90 892 NOK
Disclosure of products and services [text block]	—	—	—	—
Disclosure of products and services [abstract]
Disclosure of products and services [line items]
Disclosure of geographical areas [text block]	—	—	—	—
Disclosure of geographical areas [abstract]
Disclosure of geographical areas [line items]
Disclosure of major customers [text block]	—	—	—	—
Disclosure of major customers [abstract]
Disclosure of major customers [line items]